Beyond Meat's Third Consecutive Quarter of Worse-Than-Expected Results Approaches
Beyond Meat reports second quarter 2026 earnings after market close on August 5, 2026, with analysts expecting a loss of $0.08 per share on revenue of $64.80 million. The plant-based protein company faces a critical test as it attempts to demonstrate progress in its turnaround efforts amid persistent losses and declining sales, with the stock trading near all-time lows and Wall Street maintaining a deeply pessimistic outlook.
Part 1: Earnings Preview
Beyond Meat develops, manufactures, and markets plant-based meat alternatives designed to replicate the taste and texture of animal protein, selling products through retail and foodservice channels across multiple categories including burgers, sausages, and chicken substitutes.
The company is scheduled to report Q2 2026 results after market close on Wednesday, August 5, 2026, with a conference call at 5:00 PM Eastern. Analysts expect an EPS loss of $0.08, which would represent significant improvement from the $0.43 loss reported in Q2 2025 (same quarter last year) and a modest improvement from the $0.10 loss reported in Q1 2026. Revenue is estimated at $64.80 million, down 18.9% year-over-year from the $74.96 million reported in Q2 2025.
Three key themes define this earnings story:
Loss Reduction Progress: The consensus estimate of a $0.08 loss represents an 81% improvement versus the prior-year quarter, suggesting analysts believe Beyond Meat's cost-cutting and operational efficiency initiatives are gaining traction. However, the company remains deeply unprofitable, and investors will scrutinize whether this improvement reflects sustainable operational progress or merely temporary factors.
Revenue Stabilization Challenge: With revenue expected to decline nearly 19% year-over-year, Beyond Meat continues to face significant headwinds in both retail and foodservice channels. The company must demonstrate it can stabilize its top line and reverse the persistent volume declines that have plagued recent quarters, particularly as consumer interest in plant-based proteins has cooled from pandemic-era peaks.
Credibility and Execution: After missing revenue estimates in multiple recent quarters and delivering a significant Q4 2025 EPS miss, Beyond Meat faces a credibility gap with investors. Management's ability to meet or exceed guidance will be critical, as will any commentary on the path to profitability and cash flow sustainability.
Analysts have generally reconfirmed their estimates over the last 30 days, suggesting expectations are stable heading into the print. However, the broader analyst community remains deeply skeptical, with the stock carrying an average price target of just $0.70 and a consensus rating that skews heavily toward sell recommendations.
Part 2: Historical Earnings Performance
Beyond Meat's recent earnings track record reveals a pattern of persistent misses and deteriorating execution. Over the past four quarters, the company has missed EPS estimates three times while beating only once, with an average surprise of -28.96% when excluding the most recent quarter's modest beat.
The Q1 2026 report delivered a rare positive surprise, with a loss of $0.10 versus the $0.12 estimate (16.67% beat). However, this followed a disastrous Q4 2025 result where the company reported a $0.29 loss against a $0.12 estimate—a massive 141.67% miss that severely damaged credibility. The two quarters prior (Q3 and Q2 2025) also saw misses of 14.63% and 16.22%, respectively.
The pattern suggests operational unpredictability and difficulty forecasting results, with the company struggling to meet even reduced expectations. The single recent beat in Q1 2026 appears more exception than rule, and investors will be watching closely to see whether Beyond Meat can deliver consecutive quarters of meeting or beating estimates—something it has failed to accomplish over the past year.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $-0.37 | $-0.43 | -16.22% | Miss |
| Sep 2025 | $-0.41 | $-0.47 | -14.63% | Miss |
| Dec 2025 | $-0.12 | $-0.29 | -141.67% | Miss |
| Mar 2026 | $-0.12 | $-0.10 | +16.67% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Beyond Meat reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-06 | +$0.12 (+13.22%) | $0.13 (14.15%) | -$0.15 (-14.15%) | $0.05 (4.81%) |
| 2026-03-31 | +$0.09 (+15.09%) | $0.11 (18.44%) | -$0.08 (-11.57%) | $0.06 (9.11%) |
| 2025-11-10 | -$0.05 (-3.60%) | $0.17 (12.23%) | -$0.12 (-8.96%) | $0.16 (11.94%) |
| 2025-08-06 | -$0.18 (-5.81%) | $0.15 (5.00%) | -$0.12 (-4.11%) | $0.22 (7.36%) |
| 2025-05-07 | +$0.02 (+0.79%) | $0.09 (3.57%) | -$0.20 (-7.87%) | $0.27 (10.43%) |
| 2025-02-26 | -$0.16 (-4.30%) | $0.25 (6.59%) | -$0.38 (-10.67%) | $0.55 (15.45%) |
| 2024-11-06 | +$0.20 (+3.13%) | $0.48 (7.52%) | -$0.74 (-11.25%) | $0.45 (6.84%) |
| 2024-08-07 | -$0.06 (-1.13%) | $0.43 (8.11%) | +$1.29 (+24.62%) | $1.28 (24.42%) |
| Avg Abs Move | 5.88% | 9.45% | 11.65% | 11.29% |
Beyond Meat's stock exhibits extreme volatility around earnings releases, with an average absolute Day 0 move of 5.88% and Day +1 move of 11.65%—both substantially higher than typical stocks. The Day 0 range averages 9.45%, while Day +1 range averages 11.29%, indicating significant intraday swings as traders digest results.
The most recent earnings (Q1 2026 on May 6) saw a 13.22% Day 0 gain followed by a 14.15% Day 1 decline, illustrating the stock's tendency for sharp reversals. The prior quarter (Q4 2025) showed a similar pattern with a 15.09% Day 0 gain followed by an 11.57% Day 1 drop. Notably, the August 2024 report produced the most dramatic reaction: a modest 1.13% Day 0 decline followed by a massive 24.62% Day 1 surge.
The historical pattern suggests investors should prepare for double-digit percentage moves in either direction, with particular volatility extending into the session following the initial reaction.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/07/26 (DTE 3) |
| Expected Move | $0.1360 (21.46%) |
| Expected Range | $0.4977 to $0.7697 |
| Implied Volatility | 339.52% |
The options market is pricing an expected move of 21.46% (±$0.14 from the current $0.63 price), which is substantially higher than the average historical Day 0 move of 5.88% but roughly in line with the combined two-day average absolute move of approximately 17.5%. This elevated implied volatility reflects heightened uncertainty and suggests options traders are anticipating a more dramatic reaction than typical recent earnings events.
Part 3: What Analysts Are Saying
Wall Street maintains a deeply bearish stance on Beyond Meat, with an average analyst rating of 2.00 (Sell) and a mean price target of $0.70—implying just 10.5% upside from the current $0.63 price. The analyst community is sharply divided between skeptics and outright bears: 3 analysts rate the stock Hold while 3 rate it Strong Sell, with zero buy recommendations at any level.
The consensus has remained unchanged over the past month, with the same 2.00 average rating and identical distribution of recommendations. Price targets range from a low of $0.50 (21% downside) to a high of $1.00 (58% upside), but the narrow mean target of $0.70 suggests limited conviction even among the most optimistic analysts.
This pessimistic outlook reflects persistent concerns about Beyond Meat's ability to return to growth, achieve profitability, and navigate an increasingly competitive plant-based protein market where consumer enthusiasm has waned significantly from earlier peaks. The lack of any buy-rated analysts underscores the credibility challenges facing management and the steep execution hurdles ahead.
Part 4: Technical Picture
Beyond Meat enters earnings with a Sell signal at 88%, showing modest improvement from the 100% Sell reading one week ago but deteriorating from the 72% Sell signal one month ago. The technical picture remains decidedly negative across all timeframes.
Timeframe Analysis:
- Short-term (50% Sell): Moderate sell signal indicates near-term momentum remains negative despite recent stabilization
- Medium-term (100% Sell): Strong sell signal reflects persistent weakness in the intermediate trend
- Long-term (100% Sell): Strong sell signal confirms the stock remains in a deeply entrenched downtrend
Trend Characteristics: The trend is characterized as Weak but Strengthening, suggesting the stock may be attempting to form a base after severe declines, though the overall technical environment remains fragile heading into earnings.
The stock is trading at $0.63, positioned above its 5-day ($0.58), 10-day ($0.57), and 20-day ($0.60) moving averages, indicating short-term stabilization. However, it remains below all longer-term moving averages: the 50-day ($0.68), 100-day ($0.73), and 200-day ($0.90), confirming the stock is in a sustained downtrend with overhead resistance at multiple levels.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $0.5797 | 50-Day MA | $0.6752 |
| 10-Day MA | $0.5704 | 100-Day MA | $0.7289 |
| 20-Day MA | $0.5993 | 200-Day MA | $0.9024 |
Key resistance levels cluster between $0.68 and $0.73 where the 50-day and 100-day moving averages reside, while the 200-day moving average at $0.90 represents a distant ceiling. The stock's position above short-term moving averages provides minimal support, but the overall setup remains cautionary heading into earnings. With the stock trading near all-time lows and facing significant overhead resistance, any disappointment could trigger another leg lower, while even a positive surprise would face multiple technical barriers on any rally attempt. The extreme bearish positioning and weak long-term trend suggest limited downside cushion if results or guidance disappoint.